Evidence map›Paper›PMID 26305216›Full record

ArticlePloS one2015

Increased Blood-Reelin-Levels in First Episode Schizophrenia.

Tobias Hornig, Carola Haas, Lukas Sturm, Bernd Fiebich, Ludger Tebartz van Elst

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tobias HornigDepartment of Psychiatry, Albert-Ludwigs-University, Hauptstr. 5, 79104 Freiburg, Germany.
Carola HaasDepartment of Neurosurgery, Exp. Epilepsy Research, Albert-Ludwigs-University, Breisacher Strasse 64, 79106 Freiburg, Germany.
Lukas SturmDepartment of Psychiatry, Albert-Ludwigs-University, Hauptstr. 5, 79104 Freiburg, Germany.
Bernd FiebichDepartment of Psychiatry, Albert-Ludwigs-University, Hauptstr. 5, 79104 Freiburg, Germany.
Ludger Tebartz van ElstDepartment of Psychiatry, Albert-Ludwigs-University, Hauptstr. 5, 79104 Freiburg, Germany.
University of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundReelin is an extracellular glycoprotein involved in several functions of brain development, synaptogenesis and dendritic proliferation. Numerous studies found perturbation in the reelin system and altered serum reelin levels in neuropsychiatric patients using the western blot procedure. In the international literature, this is the first study that made use of an enzyme-linked immunosorbent assay to analyze serum reelin protein concentration quantitatively. RATIONALE: In order to study possible alterations in reelin blood levels in schizophrenia, we analyzed this signal in schizophrenic patients with a first episode hallucinatory and paranoid syndrome and control subjects in a pilot study design.

resultsWe found increased blood reelin protein concentration in schizophrenic patients compared to healthy controls. DISCUSSION: Our findings point to a relevant role of reelin metabolism in the pathogenesis of schizophrenia.Reelin could be a biomarker for the course of disease or psychopharmacological treatment.

conclusionWe conclude that the reelin protein blood concentration might be a relevant signal with respect to the pathophysiology of schizophrenia.

Indexed as

AdultCase-Control StudiesCell Adhesion Molecules, NeuronalDemographyExtracellular Matrix ProteinsFemaleHumansMaleNerve Tissue ProteinsReelin ProteinSchizophreniaSerine EndopeptidasesCell Adhesion Molecules, NeuronalExtracellular Matrix ProteinsNerve Tissue ProteinsReelin ProteinRELN protein, humanSerine Endopeptidases

Identifiers

PMID26305216
PMCPMC4549220
OpenAlexW1883283248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.